Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN125 Dose Finding in Lymphoma
NCT00364468Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2006
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in neutropenia, sponsored by Kyowa Kirin. Started Mar 2006; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00364468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364468.